# BIOSOLVE-IV Magmaris Swiss Satellite Registry

> **NCT04025788** · — · TERMINATED · sponsor: **University Hospital, Geneva** · enrollment: 10 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Magmaris Resorbable Magnesium Scaffold (RMS)

## Key facts

- **NCT ID:** NCT04025788
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-26
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow enrolment. New generation BRS available
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04025788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04025788, "BIOSOLVE-IV Magmaris Swiss Satellite Registry". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04025788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*